Treatment · March 29, 2026
New Triple Action Weight Loss Drug Shows Promise in Advanced Trials
An experimental weight loss drug shows transformative potential for patients seeking new treatment options....
Treatment · March 22, 2026
FDA Approves Higher-Dose Semaglutide for Weight Management Following Accelerated Review
Higher-dose semaglutide receives FDA approval through accelerated review, expanding treatment options....